Skin Regeneration Stem Cell Therapy Global Market Report 2025

The skin regeneration stem cell therapy market size has grown rapidly in recent years. It will grow from $8.14 billion in 2024 to $9.19 billion in 2025 at a compound annual growth rate (CAGR) of 12.9%. The growth in the historic period can be linked to increasing prevalence of chronic wounds, rising demand for skin graft alternatives, growing awareness of regenerative medicine, increasing number of burn injuries, and rising healthcare expenditure.

The skin regeneration stem cell therapy market size is expected to see rapid growth in the next few years. It will grow to $14.75 billion in 2029 at a compound annual growth rate (CAGR) of 12.5%. The growth in the forecast period can be driven by rising prevalence of diabetic foot ulcers, growing demand for minimally invasive treatments, expansion of stem cell research programs, increasing clinical trial success rates, and growing investment in healthcare infrastructure. Major trends in the forecast period include technological advancements in stem cell culture, innovations in tissue engineering, development of bioengineered skin substitutes, increased investment in research and development, and advancements in cell-based delivery systems.

The rising focus on regenerative medicine is expected to drive the growth of the skin regeneration stem cell therapy market. Regenerative medicine is a scientific field dedicated to repairing, replacing, or regenerating damaged cells, tissues, or organs to restore normal function. This focus is increasing due to the growing prevalence of chronic and degenerative diseases, as regenerative approaches offer the potential to restore damaged tissues and provide long-term healing beyond symptom management. Skin regeneration stem cell therapy supports this trend by advancing cell-based treatments that repair and rejuvenate damaged or aging skin. For example, in November 2025, the U.S. Food and Drug Administration (FDA) recorded 35 regenerative medicine advanced therapy (RMAT) designation requests in fiscal year 2023, up from 30 requests in fiscal year 2022, reflecting rising activity in the field.

Companies in the skin regeneration stem cell therapy market are increasingly leveraging injury-mimetic treated mesenchymal stem cells to enhance regenerative outcomes. These stem cells are preconditioned under simulated injury conditions to boost the secretion of regenerative factors, promote collagen synthesis, and accelerate skin repair. For instance, in January 2025, Robles BioCeutics LLC, a U.S.-based regenerative dermatology company, launched Glowselle - a stem cell-powered cosmetic product that enhances collagen production, delivers regenerative factors through skin-permeable formulations, and employs injury-mimetic treated mesenchymal stem cells for optimized regenerative effects.

In May 2025, AOP Health, an Austria-based healthcare technology company, partnered with RHEACELL GmbH & Co. KG to develop therapies for epidermolysis bullosa (commonly known as “butterfly children’s disease”) and chronic venous ulcers. The collaboration combines AOP Health’s commercialization expertise with RHEACELL’s advanced stem cell research to deliver innovative treatments for severe, inflammation-driven skin diseases. RHEACELL is a Germany-based, late-stage, fully integrated biopharmaceutical company specializing in stem cell therapies for high unmet medical needs in skin regeneration.

Major companies operating in the skin regeneration stem cell therapy market are KenCare Holdings Pte Ltd, Vericel Corporation, AVITA Medical Inc., Celularity Inc., StemRIM Inc., Stem Health Plus Ltd., Castle Creek Biosciences, Cutiss AG, Bioscience Institute S.p.A., Acorn Biomedical Inc., RepliCel Life Sciences Inc., Anterogen Co. Ltd., Cynata Therapeutics Limited, TOPs Cells Co. Ltd., STEM CELLS CARE (INDIA) PRIVATE LIMITED, R3 Stem Cell LLC., Lipogems International S.p.A., PolarityTE Inc., CellReg Aesthetics GmbH, MITAKY High-Tech Corporation.

North America was the largest region in the skin regeneration stem cell therapy market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in skin regeneration stem cell therapy report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. The countries covered in the skin regeneration stem cell therapy market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the healthcare sector, particularly in the supply of critical medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are facing higher costs for imported surgical instruments, imaging equipment, and consumables such as syringes and catheters, many of which have limited domestic alternatives. These increased costs are straining healthcare budgets, leading some providers to delay equipment upgrades or pass on expenses to patients. Additionally, tariffs on raw materials and components are disrupting the production of essential drugs and devices, causing supply chain bottlenecks. In response, the industry is diversifying sourcing strategies, boosting local manufacturing where possible, and advocating for tariff exemptions on life-saving medical products.

The skin regeneration stem cell therapy market research report is one of a series of new reports that provides skin regeneration stem cell therapy market statistics, including the skin regeneration stem cell therapy industry global market size, regional shares, competitors with the skin regeneration stem cell therapy market share, detailed skin regeneration stem cell therapy market segments, market trends, and opportunities, and any further data you may need to thrive in the skin regeneration stem cell therapy industry. This skin regeneration stem cell therapy market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

Skin regeneration stem cell therapy is a regenerative medicine technique that uses stem cells to repair, restore, or rejuvenate damaged skin tissue, promoting healing, reducing scarring, and improving the skin’s structure, function, or appearance. This therapy leverages the ability of stem cells to differentiate into various skin cell types and release growth factors and cytokines that accelerate skin regeneration, making it suitable for treating wounds, burns, ulcers, scars, and age-related skin conditions.

The key types of skin regeneration stem cell therapy include autologous and allogeneic stem cell treatments. Autologous therapies use a patient’s own stem cells. The different cell sources include adipose-derived stem cells, bone marrow-derived stem cells, and umbilical cord-derived stem cells. Key applications include burn treatment, chronic wound healing, cosmetic surgery, and skin rejuvenation, and the therapies are used by various end users such as hospitals, cosmetic clinics, and research laboratories.

The skin regeneration stem cell therapy market consists of revenues earned by entities by providing services such as stem cell isolation and processing services, cryopreservation and storage services, clinical therapy services, research and development services, regulatory and quality assurance services, and post-treatment monitoring and follow-up care services. The market value includes the value of related goods sold by the service provider or included within the service offering. The skin regeneration stem cell therapy market also includes sales of stem cell-based skin grafts and patches, regenerative skin creams and serums, cell therapy kits, regenerative scaffolding systems, and bioactive wound gels. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 3-5 business days.